Standex International Corp/de/ Form 4 insider transactions
NYSE
Standex International Director Robin J Davenport received a grant of 639 shares of common stock as restricted stock, vesting in three years.
NYSE
Barbara Joanne Edwards, a Director at Standex International Corp, received a grant of 639 shares of common stock under the company's incentive plan.
NYSE
Standex International Director Andy L. Nemeth was granted 639 shares of restricted common stock, increasing his beneficial ownership to 6,639 shares.
NYSE
Standex International Director Charles H. Cannon Jr. was granted 639 shares of common stock as restricted stock, vesting in three years.
NYSE
Standex International Director Thomas J. Hansen retired, leading to the vesting of his phantom stock units into common shares.
NYSE
Standex International Corp. President, CEO, and Chairman David A. Dunbar sold 18,000 shares of common stock for $235 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Standex International's VP & Chief Accounting Officer, Danielle Rangel, acquired 7 shares of common stock through an employee stock purchase plan.
NYSE
Standex International Corp's President, CEO, and Chairman, David A. Dunbar, sold 11,000 shares of common stock for $215 per share under a pre-arranged 10b5-1 trading plan.
NYSE
Standex International Corp's President, CEO, and Chairman, David A. Dunbar, transferred 17,397 shares of common stock to a revocable trust.
NYSE
Standex International's VP, Chief HR Officer, Annemarie Bell, sold 1,184 shares of common stock for $202.12 per share under a Rule 10b5-1 plan.
NYSE
Standex International Director Andy Nemeth filed a Form 4 indicating a planned acquisition of 1,500 shares of common stock at $205 per share on August 29, 2025, under a Rule 10b5-1 plan.
NYSE
Standex International's VP/CFO/Treasurer, Ademir Sarcevic, sold 1,085 shares of common stock for approximately $209.86 per share on August 26, 2025, under a Rule 10b5-1 plan.
NYSE
Standex International's VP & Chief Accounting Officer, Danielle Rangel, reported the vesting of restricted stock units, tax-related share sales, and new equity awards.
NYSE
Standex International Corp's CLO, VP & Secretary, Alan J. Glass, reported multiple acquisitions of common stock through vesting and subsequent sales for tax obligations, alongside new equity awards.
NYSE
Annemarie Bell, VP and Chief HR Officer at Standex International, reported vesting of equity awards and subsequent tax-related share sales.
NYSE
Standex International's President, CEO, and Chairman, David A. Dunbar, reported the vesting of various equity awards and subsequent tax-related share dispositions, alongside new equity grants.
NYSE
Standex International's CFO, Ademir Sarcevic, reported scheduled vesting of equity awards and subsequent tax-related stock sales, alongside new performance and restricted stock unit grants.
NYSE
Standex International's VP and CIO, Max Arets, reported the vesting of restricted stock units, a tax-related share sale, and new equity awards.
NYSE
Standex International Director Barbara Joanne Edwards acquired 387 shares of common stock through the vesting of phantom stock units and received a new grant of 209 phantom stock units.
NYSE
Standex International Director Thomas J. Hansen reported the vesting of 1,107 phantom stock units and the acquisition of 599 new phantom stock units under company plans.
NYSE
Standex International Director Andy L. Nemeth acquired 2,000 shares of common stock at a weighted average price of $209.4959 per share.
NYSE
Standex International Director Robin J. Davenport was granted 149 phantom stock units, vesting in three years, under the company's incentive plan.
NYSE
Standex International Director Charles H. Cannon Jr. acquired 599 phantom stock units under the company's incentive plan.
NYSE
Standex International's VP and Chief Information Officer, Max Arets, increased his beneficial ownership of common stock through the company's Dividend Reinvestment Plan.
NYSE
Standex International Director Robin J. Davenport acquired additional common stock through the company's Dividend Reinvestment Plan.
NYSE
Standex International Director Thomas J. Hansen sold 2,992 shares of common stock for approximately $202.60 per share on August 18, 2025, under a pre-arranged trading plan.
NYSE
Standex International's President and CEO, David A. Dunbar, reported a future sale of 16,000 shares of common stock at $200 per share under a pre-arranged 10b5-1 trading plan.
NYSE
An amended SEC Form 4 clarifies that a recent sale of 2,779 Standex International shares was executed by a trust, not directly by Director Charles H. Cannon Jr.
NYSE
Standex International's CFO, Ademir Sarcevic, sold 3,047 shares of common stock for approximately $191.80 per share, as part of a pre-arranged Rule 10b5-1 plan.
NYSE
Max Arets, VP and Chief Information Officer of Standex International Corp, acquired 28 shares of common stock at $133.008 per share through the company's Employee Stock Purchase Plan.